BCR and chronic myelogenous leukemia, BCR-ABL1 positive: 107 Douxfils Douxfils J J Haguet Haguet H H Mullier Mullier F F Chatelain Chatelain C C Graux Graux C C Dogne Dogne JM JM Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis JAMA Oncol JAMA Oncol 2016 2016 2 2 5 5 625 625 632 632 26847662 26847662 107.